Ingredient deep-dive

Does The Metabolic Boost From Caffeine Fade? What The Tolerance Studies Show

Caffeine tolerance is real, well documented, and happens fast — within days, not months. What is less widely known is that it does not happen evenly. Some of caffeine’s effects fade almost completely with daily use. At least one does not.

By SlimSet Team · Last updated September 27, 2026 · 10 min read · Ingredient deep-dive

Why this question matters for a daily capsule

This capsule is designed to be taken once a day, every day, per the label. That routine puts a specific question on the table that a single-dose laboratory study cannot answer: does whatever caffeine does on day one still happen on day thirty, or does the body adapt and quietly cancel the effect out? The honest answer, built from several decades of caffeine pharmacology research, is that it depends entirely on which effect you mean.

The 1981 trial: tolerance in one to four days

The foundational study here is a 1981 trial published in the Journal of Clinical Investigation. The researchers established first that acute caffeine, in subjects who did not normally consume methylxanthines, produced measurable rises in blood pressure, heart rate, plasma epinephrine, plasma norepinephrine, plasma renin activity and urinary catecholamines — a full cluster of stimulant cardiovascular and hormonal effects. They then gave the same subjects chronic caffeine in a double-blind design and re-measured the same variables.

Near-complete tolerance to both the humoral and hemodynamic effects developed over the first one to four days of continued caffeine. By the end of the observation period, no long-term effect of caffeine on blood pressure, heart rate, plasma renin activity, or plasma and urinary catecholamines could be demonstrated at all. This is one of the fastest, most complete tolerance effects documented for any commonly used stimulant.

What did not happen when caffeine stopped

The same 1981 trial also tested what happened when caffeine was withdrawn after 7 days of regular use, and found no detectable withdrawal phenomenon in any of the measured variables. This particular finding has been complicated by later research using more sensitive measures and larger samples, which is why a separate article on this site covers caffeine withdrawal symptoms in full using that later literature. The point relevant here is narrower: the 1981 trial’s own tolerance finding, at least, was not an artefact of the body being thrown off balance and struggling to readjust — the cardiovascular and hormonal systems settled back to an unstimulated baseline cleanly.

Not every system tolerizes the same way

A follow-up question is whether tolerance is a single, uniform switch or something that happens separately in different body systems. A 1995 trial in Clinical Science addressed this directly. Nine healthy volunteers had their cerebral blood flow velocity, blood pressure, heart rate and stress hormones measured, first after a single acute 250 mg caffeine dose and again after six days of regular caffeine use, both at rest and during a standing (orthostatic) challenge.

After six days, the pressor effect on blood pressure and the rise in plasma adrenaline were both significantly attenuated, echoing the 1981 findings. But the drop in cerebral blood flow velocity that acute caffeine produced was not reduced by chronic use at all — it persisted essentially unchanged. The researchers describe this directly as a dissociation between central and peripheral tolerance: the brain's blood vessels and the cardiovascular/hormonal system adapt to daily caffeine on different schedules, or not at all.

Nine healthy volunteers, double-blind acute phase followed by six days of open-label chronic use. A small trial, but a directly relevant one on the specific question of whether tolerance is uniform.

The exception: exercise performance did not fade

The clearest large-scale answer on whether a caffeine benefit specifically survives daily use comes from sports science rather than cardiovascular pharmacology. A 2022 systematic review and meta-analysis in Sports Medicine pooled 60 caffeine-and-exercise studies that reported participants’ habitual daily caffeine intake, specifically to test whether being a heavy daily consumer blunted caffeine’s acute performance-enhancing effect.

It found no influence of habitual caffeine consumption on the ergogenic effect at all, whether the acute dose was below, within, or above a participant’s usual intake, and regardless of how many hours they had abstained beforehand. Caffeine improved endurance, power and strength performance similarly in light and heavy daily consumers alike. This stands in direct contrast to the cardiovascular tolerance documented above — whatever mechanism gives caffeine its performance edge does not appear to follow the same fast-tolerizing pathway as its effect on blood pressure and adrenaline.

The question nobody has directly answered

What none of the trials above tested is the specific effect this capsule’s ingredient list is most often associated with on a weight-management sales page: the thermogenic, metabolic-rate-raising effect measured in the classic caffeine-and-energy-expenditure trials. No study identified for this article directly re-ran that specific measurement — resting metabolic rate under a ventilated hood — comparing caffeine-naive and long-term daily coffee-drinking volunteers side by side.

A rough timeline, built from the trials above

Putting the 1981 and 1995 trials on a single timeline is useful, with the caveat that both used small samples and their own study doses — the 1995 trial's acute dose was 250 mg — not this capsule’s 138 mg specifically.

• Day 1 (naive user, first dose): full acute effect — the blood pressure rise, adrenaline rise and cerebral blood flow drop the 1981 and 1995 trials measured before any chronic dosing.
• Days 1–4: the 1981 trial found near-complete tolerance to the blood pressure and hormonal effects developing within this window.
• Day 6: the 1995 trial's chronic-use measurement point, where blood pressure and adrenaline responses were significantly attenuated but cerebral blood flow response was not.
• Day 7 onward, after stopping: the 1981 trial's withdrawal-testing window, where no humoral or hemodynamic withdrawal effect was detected in that particular dataset.
• Every day, indefinitely, for a habitual user: the 2022 review's finding — no reduction in exercise-performance benefit, however long the habit has run.

The honest gap in this timeline is the metabolic-rate measurement itself, which sits in none of these trials and is the piece a marketing claim about “everyday fat metabolism” would need to close.

One more piece worth naming: none of the tolerance research above was conducted using this capsule’s specific combination of caffeine anhydrous alongside green coffee and green tea extracts, both of which carry their own additional, undeclared caffeine. The tolerance trials used caffeine on its own, at their own study doses. Whether a multi-source daily caffeine intake tolerizes on exactly the same one-to-four-day schedule as a single-source dose has not been directly tested either, as far as this article could establish.

What this means for a daily capsule

Put together, the honest picture is this: caffeine’s blood pressure and stress-hormone response very likely fades substantially within the first few days of daily capsule use, based on the clearest tolerance data available. Its effect on brain blood flow may not fade the same way. Its exercise-performance benefit, based on the largest pooled dataset available, does not appear to fade with daily use at all. And its specific thermogenic effect — the one most closely tied to a weight-management claim — has not been directly re-tested for tolerance in the published literature this article could locate.

• Alertness and jitteriness in week one, easing by week two, is consistent with the fast cardiovascular/hormonal tolerance documented above.
• A pre-workout benefit is not expected to fade with continued daily use, per the largest available pooled dataset.
• A metabolic-rate claim specifically should be read with the caveat that its own tolerance profile has not been directly measured.
• Blood pressure and heart-rate changes in the first few days are the expected acute pattern, not a sign anything is wrong, based on the trials above — though anyone with an existing cardiovascular condition should still raise a new daily stimulant with whoever manages that condition before starting.

A week of simple notes — resting heart rate on waking, and a one-to-five alertness rating at mid-morning — is enough to see the days-one-to-four tolerance pattern described above play out in your own body, rather than taking the trial data on faith.

The article totaling this capsule’s full caffeine load is a useful companion piece for anyone tracking their own daily intake against these patterns.

Related reading: caffeine and exercise: the dose gap covers the performance literature this article draws its tolerance contrast from, and stopping a caffeine capsule covers what happens on the other end, once the capsules stop, using the fuller and more recent withdrawal literature than the single null finding in the 1981 trial above.

References